Urologix negotiates Medtronic licensing deal; German retina implant company wins CE mark;

 @FierceMedDev: Device tax opponents may have gained their opening. Item | Follow @FierceMedDev

 @MarkHFierce: Give us your FMD Fierce 15 nominations today. And spread the word.... More | Follow @MarkHFierce

 @DamianFierce: GI Dynamics has raised $52.2M to get its anti-obesity device through the FDA process. Story | Follow @DamianFierce

> Devicemaker Urologix ($ULGX) has renegotiated its licensing deal with Medtronic ($MDT), delaying payment of the $7.5 million the company owes. Article

> Israeli startup V Wave raised $2 million from Pontifax and others to support development of a miniature valve implant designed to manage blood flow between the heart chambers. Story

> Imaging Dynamics, a medical imaging company, will raise nearly $1.4 billion through a massive new private placement. Item   

> Retina Implant AG in Germany won a CE mark for a wireless subretinal electronic chip implant designed to restore vision to patients suffering from retinitis pigmentosa. Item

> Idaho's Numotion has acquired ATS Wheelchair and Medical, maker of mobility devices, for an undisclosed sum. More

> Patients who used at-home blood pressure monitors kept their levels in line better than those without, according to a study. Story

> InSightec secured an extended CE mark for its ExAblate ultrasound therapy systems to treat cancerous and benign primary and secondary tumors. Story

> Cancer diagnostic firm GeneCentric is raising $5 million. Item (sub. req.)

Biotech News

 @FierceBiotech: Researchers spotlight two cases of eradicated HIV infection. Story | Follow @FierceBiotech

 @JohnCFierce: FDA cuts the regulatory fuse on Roche's heir to Rituxan. More | Follow @JohnCFierce

 @RyanMFierce: GlaxoSmithKline, J&J make early progress with monthly HIV combo. News | Follow @RyanMFierce

 @EmilyMFierce: Texas A&M launches multimillion-dollar genomics research project. Item | Follow @EmilyMFierce

> Report: Sanofi trims R&D jobs in France in scaled-down reorganization. News

> Biogen R&D exec Gilman hits the exit door. Item

Pharma News

 @FiercePharma: Chile's CFR Pharma offers $1.3B for leading South African drug maker Adcock Ingram. Will Bidvest come back? Article | Follow @FiercePharma

 @CarlyHFierce: ICYMI: King Pharmaceuticals settles for $2.2M after violating pharma emissions standards. More | Follow @CarlyHFierce

> Drugmakers to open their doc-payment books in Europe. News

> Under new scrutiny, foreign firms 'have to be careful' in China, experts say. More

> Study confirms pharma's austerity pain in Europe. Story

Drug Delivery News

 @MichaelGFierce:  Mass-produced nanoparticles for drug delivery show market potential. More | Follow @MichaelGFierce

> Avanir drops $110M on novel inhaled-delivery migraine device. News

> UVA researchers find enzyme target for glioblastoma, cancer treatment. Story

> High-dose schizophrenia treatment crosses blood-brain barrier. Read

> Alnylam reports two more positive trials in RNAi arena. More